A Common Virus Emerging as Potential Culprit in Alzheimer’s Disease 

New research adds to evidence that a common herpes virus increases the risk of the neurogenerative condition. 
A Common Virus Emerging as Potential Culprit in Alzheimer’s Disease 
(Monika Wisniewska/Shutterstock)
George Citroner
3/29/2024
Updated:
4/2/2024

The silent terror of Alzheimer’s disease is slowly robbing millions of their memories and cognitive abilities.

Advanced age and genetics have long been identified as risk factors for this condition, but a new study has uncovered a surprising—and very common—new culprit that may be contributing to the cognitive decline: the herpes simplex virus, known for causing cold sores.

Herpes Simplex Virus May Double Risk of Alzheimer’s

In a Swedish study published in February in the Journal of Alzheimer’s Disease, researchers examined a group of more than 1,000 cognitively healthy 70-year-olds over 15 years. The participants were assessed at baseline, then again at ages 75 and 80, and their medical records were followed until age 85.

The researchers analyzed blood samples to detect signs of previous infection with herpes simplex virus (HSV) types 1 and 2, as well as the presence of the apolipoprotein E4 (APOE 4) genetic mutation, which is associated with an increased risk of Alzheimer’s disease.

The study found that individuals who had been infected with HSV-1 at some point in their lives had twice the risk of developing dementia compared with those who had never been infected.

Although this study adds to similar results from previous research, it is the first to associate HSV-1 with cognitive decline in participants who were all the same age at the start of the study.

This makes the results “more reliable since age differences, which are otherwise linked to the development of dementia, cannot confuse the results,” according to Erika Vestin, a medical student at Uppsala University and co-author of the study.

“More and more evidence is emerging from studies that, like our findings, point to the herpes simplex virus as a risk factor for dementia,” she said in a statement.

Herpes infections are widespread in the United States, with 50 percent to 80 percent of American adults infected with oral herpes caused by HSV-1, which can cause cold sores or fever blisters to appear in or around the mouth.

Still No Definitive Evidence: Expert

Although the line of inquiry into viruses and other disease-related microorganisms in the brain and gut is not new, these are currently hot topics in neuroscience, Stefania Forner, Alzheimer’s Association director of medical and scientific relations, told The Epoch Times.

One of the primary questions being investigated is whether these microorganisms play an active, causative role in the disease or if they “opportunistically enter the brain,” taking advantage of the damage caused by Alzheimer’s, she said.

There is currently no definitive evidence of a causal relationship between these microorganisms and Alzheimer’s disease, Ms. Forner said, adding that Alzheimer’s is a complex disease with many contributing factors, and multiple causes likely contribute to its underlying biology.

The new study doesn’t prove that herpes viruses caused the onset or contributed to the progression of Alzheimer’s disease, nor does it suggest that antiviral treatment can treat or prevent the condition, according to Ms. Forner.

“The numbers involved are small, and more research needs to be done in historically underrepresented populations,” she added. “Overall, more research is needed to better understand how viral infections and brain health are linked.”

Understanding Viral Links Critical for Future Treatments

“Increasingly, we know the immune system plays an important role in the underlying biology of Alzheimer’s,” Ms. Forner said. “As a result, there are an increasing number of clinical trials targeting immune-related mechanisms.”
Herpes simplex virus has been found in the brains of some people with Alzheimer’s, and it may be associated with increased accumulation of beta-amyloid plaques and tau tangles, two of the hallmark brain changes in Alzheimer’s.

However, understanding the potential connections between viruses, microbes, and Alzheimer’s risk could open up new avenues for treatment development.

As an example, Ms. Forner pointed to the Alzheimer’s Association’s funding of a phase 2 clinical trial through its Part the Cloud initiative. This trial investigates whether an antiviral medication can reduce brain changes and cognitive or memory symptoms seen in mild cognitive impairment.

COVID-19 Adds Urgency to Understanding Viral Effects on Brain

Herpes simplex virus isn’t the only pathogen linked to an increased risk of cognitive decline.
Research from 2022 found that people who survived a COVID-19 infection were at significantly higher risk for a new diagnosis of Alzheimer’s disease within 360 days after COVID-19 diagnosis, especially those aged 85 years or older and women.
In 2023, a comprehensive review of published studies investigated viruses’ ability to invade the central nervous system directly, finding evidence that COVID-19 may be related to neurodegenerative illnesses.

The COVID-19 pandemic has “multiplied the urgency” to understand how viruses may affect the brain, Ms. Forner said.

The Alzheimer’s Association is responding to this urgency by participating in the International Network to Study SARS-CoV-2 Impact on Behavior and Cognition. This network involves scientific leaders and representatives from six continents working together, with guidance from the World Health Organization, to track the long-term effects of COVID-19 on the brain.
George Citroner reports on health and medicine, covering topics that include cancer, infectious diseases, and neurodegenerative conditions. He was awarded the Media Orthopaedic Reporting Excellence (MORE) award in 2020 for a story on osteoporosis risk in men.
Related Topics